NAXLOMI Trademark

Trademark Overview

On Friday, August 13, 2010, a trademark application was filed for NAXLOMI with the United States Patent and Trademark Office. The USPTO has given the NAXLOMI trademark a serial number of 85107274. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 13, 2015. This trademark is owned by Millennium Pharmaceuticals, Inc.. The NAXLOMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
naxlomi

General Information

Serial Number85107274
Word MarkNAXLOMI
Filing DateFriday, August 13, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 13, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, April 13, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 13, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 18, 2014EXTENSION 5 GRANTED
Monday, August 11, 2014EXTENSION 5 FILED
Monday, August 11, 2014TEAS EXTENSION RECEIVED
Thursday, February 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 19, 2014EXTENSION 4 GRANTED
Thursday, February 6, 2014EXTENSION 4 FILED
Thursday, February 6, 2014TEAS EXTENSION RECEIVED
Tuesday, August 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2013EXTENSION 3 GRANTED
Monday, August 12, 2013EXTENSION 3 FILED
Monday, August 12, 2013TEAS EXTENSION RECEIVED
Monday, August 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, February 21, 2013EXTENSION 2 GRANTED
Tuesday, February 12, 2013EXTENSION 2 FILED
Thursday, February 21, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 12, 2013TEAS EXTENSION RECEIVED
Wednesday, August 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, August 6, 2012EXTENSION 1 GRANTED
Monday, August 6, 2012EXTENSION 1 FILED
Monday, August 6, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2011NOTICE OF PUBLICATION
Saturday, December 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 6, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 6, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, December 6, 2011EXAMINERS AMENDMENT MAILED
Tuesday, December 6, 2011ASSIGNED TO LIE
Tuesday, December 6, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, June 6, 2011FINAL REFUSAL MAILED
Friday, June 3, 2011FINAL REFUSAL WRITTEN
Wednesday, June 1, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 31, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 31, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 1, 2010NON-FINAL ACTION MAILED
Wednesday, December 1, 2010NON-FINAL ACTION WRITTEN
Tuesday, November 30, 2010ASSIGNED TO EXAMINER
Wednesday, August 18, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 17, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

naxlomi diseases pharmaceutical cancer treatment disorders preparations inflammatory immune malignancies human